查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520578

2024-2032 年按药物类别、製剂类型、配销通路和地区分類的抗酸剂市场报告

Antacids Market Report by Drug Class, Formulation Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年全球抗酸剂市场规模达69IMARC Group美元。该市场正在经历成长，主要是因为零售药局的扩张、对非处方药的偏好以及胃食道逆流（GERD）患者数量的增加推动了市场的成长。

抗酸剂市场分析：

主要市场驱动因素：全球患有胃食道逆流的人数不断增加，刺激了抗酸剂的需求。这是推动市场成长的关键因素之一。

主要市场趋势：西瓜薄荷、果味谷物和草莓奶昔等主要参与者推出的调味和咀嚼型抗酸药对抗酸剂市场收入产生了积极影响。

地理趋势：由于医疗保健支出不断增加、人口老化和医疗保健产业扩张，亚太地区成为抗酸剂最大的区域市场。

关键参与者：抗酸剂产业的一些主要市场参与者包括雅培实验室、阿斯特捷利康公司、拜耳公司、勃林格殷格翰国际有限公司、雷迪博士实验室有限公司、葛兰素史克公司、强生公司、辉瑞公司、宝洁公司、Reckitt Benckiser Group PLC、Sanofi SA、Sun Pharmaceutical Industries Ltd、Takeda Pharmaceutical Company Limited 等。

挑战与机会：抗酸剂市场的挑战在于胃酸逆流的替代治疗方法的存在，而机会则在于新兴市场和治疗消化问题的创新配方。

抗酸剂市场趋势：

胃食道逆流症 (GERD) 的影响

  • 根据美国国家医学图书馆 2022 年的报告，2019 年有 7.8395 亿人受到胃食道逆流的影响。抗酸剂因其多种特性而被认为是治疗胃酸过多的最佳方法。人们意识到抗酸剂可以快速缓解疼痛，并且其易于获取进一步促进了抗酸剂市场的成长。

老年人口增加导致人口结构变化

老年人越来越了解抗酸剂的重要性，因为它们具有快速缓解酸性物质的功效。因此，他们经常服用或购买抗酸剂来控制这些消化问题。可以说，人口老化率上升的国家在全球的抗酸剂销售量可能会更高。世界卫生组织（WHO）2022年报告称，到2030年和2050年，每6人中就有1人年龄在60岁或以上。 。

由于易于获取，人们对非处方药 (OTC) 的依赖日益增加

在世界范围内，非处方疗法是治疗轻微症状的首选药物，这刺激了抗酸剂的需求。抗酸剂可以透过药房、杂货店和线上平台轻鬆获得，因此在自我药疗中发挥着至关重要的作用。抗酸剂具有成本效益和节省时间的优点，非常适合当今的人们。 IMARC集团的研究报告提到，到2032年，全球非处方药（OTC）市场将达到2,759亿美元。

抗酸剂市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据药物类别、製剂类型和配销通路对市场进行了分类。

按药物类别细分：

质子帮浦抑制剂

H2拮抗剂

酸中和剂

促动力剂

质子帮浦抑制剂占大部分市场份额

该报告根据药物类别提供了详细的市场细分和分析。这包括质子帮浦抑制剂、H2 拮抗剂、酸中和剂和促动力剂。根据该报告，质子帮浦抑制剂代表了最大的部分。

质子帮浦抑制剂是如此有效和可靠，以至于每个人都希望它们能够减少胃酸和消化不良。医疗保健专业人员根据胃酸倒流的严重程度开出处方，导致其销售量更高。主要参与者正在扩大他们的市场，因为他们知道人们正在了解质子帮浦抑制剂对体内的正面影响。例如，Daewon Pharmaceutical 于 2022 年在韩国推出了首款质子帮浦抑制剂药物，名为 Escorten。

按配方类型细分：

药片

液体

粉末

其他的

平板电脑占据产业最大份额

报告还根据配方类型对市场进行了详细的细分和分析。这包括片剂、液体、粉末等。报告称，平板电脑占据了大部分市场份额。

平板电脑具有易于存放、运输和管理等优点，使其深受个人欢迎。片剂很方便，因为它们可以随时随地用水轻鬆服用。无论是在办公室、家里或旅行中，人们都可以透过片剂药物快速缓解胃酸过多或消化不良。与液体或粉末製剂类型相比，片剂的保质期延长被视为另一个优点。抗酸剂市场上存在的各种片剂配方，如咀嚼片、延迟释放片和泡腾片，进一步建立了强大的消费者基础。

按配销通路划分：

医院药房

零售药局

其他的

零售药局代表领先的细分市场

该报告根据配销通路对市场进行了详细的细分和分析。这包括医院药房、零售药房等。报告称，零售药局占据市场主导地位。

首先，世界各地的城市、郊区和农村地区都拥有众多的零售药局。抗酸剂作为非处方药非常受欢迎，零售药局是购买抗酸剂的重要管道。其次，零售药局提供的抗酸药物种类繁多，可以根据患者的喜好和需求满足不同患者的需求。第三，零售药品市场的主要竞争对手将重点放在收购和扩张上，以扩大其影响力。 Medly Pharmacy 于 2021 年收购 Pharmaca 以提供 360 度药房服务就是这样的例子。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

亚太地区引领市场，占据最大的抗酸剂市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，亚太地区在市场上享有领先地位。

印度和中国等人口稠密的国家是该地区最大的抗酸剂市场，因为这些国家正在经历生活方式的转变和西方饮食习惯，通常会导致胃酸倒流和消化不良。此外，该地区人口老化被视为抗酸剂市场的近期机会，因为他们对消化问题高度敏感。与此一致的是，亚太地区有许多竞争激烈的主要参与者，它们注重合作伙伴关係和收购来扩大市场。这是由印度製药公司 Dr. Reddy's Laboratories 于 2024 年从 Amyris Inc. 收购 MenoLabs 时完成的，以满足亚太地区人们不断变化的需求。

本报告回答的关键问题

  • 全球抗酸剂市场有多大？
  • 2024-2032年全球抗酸剂市场的预期成长率是多少？
  • 推动全球抗酸剂市场的关键因素是什么？
  • COVID-19 对全球抗酸剂市场有何影响？
  • 根据药物类别，全球抗酸剂市场的细分如何？
  • 根据製剂类型，全球抗酸剂市场的细分如何？
  • 基于配销通路的全球抗酸剂市场的细分是怎样的？
  • 全球抗酸剂市场的关键地区有哪些？
  • 全球抗酸剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球抗酸剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类别

  • 质子帮浦抑制剂
    • 市场走向
    • 市场预测
  • H2拮抗剂
    • 市场走向
    • 市场预测
  • 酸中和剂
    • 市场走向
    • 市场预测
  • 促动力剂
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按配方类型

  • 药片
    • 市场走向
    • 市场预测
  • 液体
    • 市场走向
    • 市场预测
  • 粉末
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Procter & Gamble Company
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
Product Code: SR112024A5082

The global antacids market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The market is experiencing growth mainly because of the expansion of retail pharmacies, preference for OTC drugs, and rising number of patients experiencing gastroesophageal reflux disease (GERD) are impelling the growth of the market.

Antacids Market Analysis:

Major Market Drivers: People suffering from GERD is increasing around the world, which is catalyzing the demand for antacids. This represents one of the key factors propelling the market growth.

Key Market Trends: The launch of flavored and chewable antacids drugs by key players like watermelon mint, fruity cereals, and strawberry milkshake is positively impacting the antacids market revenue.

Geographical Trends: Asia Pacific is the largest regional market for antacids because of the rising healthcare expenditure, aging population, and healthcare sector expansion.

Key Players: Some of the major market players in the antacids industry include Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., among many others.

Challenges and Opportunities: Challenges in the antacids market are the presence of alternative treatment for acid reflux, while opportunities lie in emerging markets and innovative formulations to treat digestive issues.

Antacids Market Trends:

Gastroesophageal reflux disease's (GERD) impact

  • 783.95 million people were impacted by GERD in 2019 claimed by the report of the National Library of Medicine 2022. The more people going through the suffering of GERD, the more it is driving the demand for antacids. The best treatment for acidity is thought to be antacids because of their several qualities. Individuals are aware about the quick relief provided by antacids and their easy accessibility is further contributing to the antacids market growth.

Changing demographics because of rising geriatric population

Elderly people are understanding the importance of antacids because of their quick relief qualities from acidity. They are, as a result, a regular consumer or buyer of antacids to manage these digestive issues. It may be said that nations with increased aging population rates can have higher sales of antacids worldwide. As claimed by the World Health Organization's (WHO) report of 2022, 1 individual out of 6 will be of 60 years in age or over by 2030 and by 2050. The global population of those aged 60 and over will also reach 2.1 billion, up from 1.4 billion in 2020.

Rising reliance on over the counter (OTC) medicines due to their ease of availability

Non-prescribed remedies are highly preferred in the world to cure mild symptoms, which is catalyzing the antacids demand. Antacids are easily available via pharmacies, grocery stores, and online platforms and as a result play a crucial role in self-medication purposes. The cost-effectiveness and time saving benefits provided by antacids are making them highly suitable for people nowadays. The IMARC Group's research report mentions that the global market for over the counter (OTC) drugs will reach US$ 275.9 Billion by 2032.

Antacids Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on drug class, formulation type, and distribution channel.

Breakup by Drug Class:

Proton Pump Inhibitors

H2 Antagonist

Acid Neutralizers

Pro-Motility Agents

Proton pump inhibitors accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes proton pump inhibitors, H2 antagonist, acid neutralizers, & pro-motility agents. According to the report, proton pump inhibitors represent the largest segment.

Proton pump inhibitors are so effective and reliable that everyone wants them to cut down on stomach acid and indigestion. Healthcare professionals prescribed them as per the severity of acid reflux, leading to their higher sales. Key players are expanding their market as they know people are gaining knowledge about the positive impact of proton pump inhibitors in the body. For instance, Daewon Pharmaceutical introduced its first proton pump inhibitor medicine in Korea in 2022, known as Escorten.

Breakup by Formulation Type:

Tablet

Liquid

Powder

Others

Tablet holds the largest share of the industry

A detailed breakup and analysis of the market based on the formulation type have also been provided in the report. This includes tablet, liquid, powder, and others. According to the report, tablet accounts for the majority of the market share.

Easy storage, transportation, and administration are some benefits provided by tablets make them highly preferable among individuals. Tablets are hassle-free, as they can be easily consumed with water anywhere or on the go. Whether at office, home, or travel, people can get quick relief from acidity or indigestion through tablet drugs. The extended shelf life of tablets is viewed as another benefit compared to liquid or powder formulation type. Various tablets formulations present in the antacids market like chewable, delayed release, and effervescent are further creating a strong consumer base.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Retail pharmacies represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and others. According to the report, retail pharmacies dominate the market.

In the first place, cities, suburbs, and rural areas all have numerous retail pharmacies around the world. Antacids as OTC drugs are highly popular & retail pharmacies are a significant outlet to purchase antacids. Secondly, the inclusion of a wide variety of antacids drugs in retail pharmacies can cater to several patients according to their preferences and demands. Thirdly, the focus of leading competitors in the retail pharmacy market on acquisition & expansion to increase their reach. The acquisition of Pharmaca by Medly Pharmacy in 2021 to deliver 360-degrees pharmacy services is one such example.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific leads the market, accounting for the largest antacids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific enjoys the leading position in the market.

The densely populated countries like India and China are the largest markets for antacids in this region, as these countries are undergoing lifestyle shifts and Western food habits, which generally results in acid reflux and indigestion. Moreover, aging population in the region is viewed as an antacids market recent opportunities due to their high susceptibility to digestive issues. In line with this, lots of key players are present in the Asia Pacific region that are highly competitive and focus on partnerships and acquisition to expand their market. This was done by Dr. Reddy's Laboratories, a pharma company in India, when it acquired MenoLabs from Amyris Inc. in 2024 to cater to the evolving needs of people in the Asia Pacific region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major antacids companies have also been provided. Some of the major market players in the antacids industry include:

Abbott Laboratories

AstraZeneca plc

Bayer AG

Boehringer Ingelheim International GmbH

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

Johnson & Johnson

Pfizer Inc.

Procter & Gamble Company

Reckitt Benckiser Group PLC

Sanofi S.A.

Sun Pharmaceutical Industries Ltd.

Takeda Pharmaceutical Company Limited.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

The development of new formulations and product variants is done by key players through research and development (R&D) activities. They are introducing antacid drugs with flavors such as Fruity Cereal to meet the evolving demands of consumers. Top companies are taking advantage of elevated awareness about gastrointestinal health among people in developing countries. They are also eyeing on acquiring small businesses in the market while creating opportunities via antacids market recent developments. Using the digital health solutions is the main help method, enabling them to provide better health results. One such example was presented by AstraZeneca in November 2023, which it launched Evinova, a health-tech business, to offer advanced digital health solutions.

Antacids Market News:

In 2022: Zydus Lifesciences received approval from the USFDA to introduce Famotidine tablets, which is a histamine H2 receptor blocker and plays a vital role in reducing acid amount in the stomach.

Key Questions Answered in This Report

  • 1. How big is the global antacids market?
  • 2. What is the expected growth rate of the global antacids market during 2024-2032?
  • 3. What are the key factors driving the global antacids market?
  • 4. What has been the impact of COVID-19 on the global antacids market?
  • 5. What is the breakup of the global antacids market based on the drug class?
  • 6. What is the breakup of the global antacids market based on the formulation type?
  • 7. What is the breakup of the global antacids market based on the distribution channel?
  • 8. What are the key regions in the global antacids market?
  • 9. Who are the key players/companies in the global antacids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antacids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 H2 Antagonist
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acid Neutralizers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pro-Motility Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Formulation Type

  • 7.1 Tablet
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Liquid
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Powder
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Dr. Reddy's Laboratories Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Procter & Gamble Company
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Reckitt Benckiser Group PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sun Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Takeda Pharmaceutical Company Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Antacids Market: Major Drivers and Challenges
  • Figure 2: Global: Antacids Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2023
  • Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Antacids Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Antacids Industry: SWOT Analysis
  • Figure 80: Global: Antacids Industry: Value Chain Analysis
  • Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antacids Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million US$), 2024-2032
  • Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Antacids Market: Competitive Structure
  • Table 7: Global: Antacids Market: Key Players